Susquehanna International Group’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-9,400
| Closed | -$203K | – | 14086 |
|
|
2022
Q4 | $203K | Sell |
9,400
-54,600
| -85% | -$1.15M | ﹤0.01% | 10089 |
|
|
2022
Q3 | $1.24M | Buy |
64,000
+49,800
| +351% | +$1.03M | ﹤0.01% | 6083 |
|
|
2022
Q2 | $282K | Buy |
14,200
+6,800
| +92% | +$179K | ﹤0.01% | 9739 |
|
|
2022
Q1 | $221K | Sell |
7,400
-6,000
| -45% | -$176K | ﹤0.01% | 11006 |
|
|
2021
Q4 | $312K | Sell |
13,400
-54,400
| -80% | -$1.45M | ﹤0.01% | 10402 |
|
|
2021
Q3 | $2.12M | Buy |
67,800
+27,800
| +70% | +$860K | ﹤0.01% | 5706 |
|
|
2021
Q2 | $1.41M | Sell |
40,000
-3,000
| -7% | -$97.5K | ﹤0.01% | 6832 |
|
|
2021
Q1 | $1.52M | Sell |
43,000
-600
| -1% | -$22.2K | ﹤0.01% | 6613 |
|
|
2020
Q4 | $1.64M | Sell |
43,600
-474,700
| -92% | -$17.3M | ﹤0.01% | 5539 |
|
|
2020
Q3 | $17.3M | Buy |
518,300
+485,400
| +1,475% | +$14.1M | ﹤0.01% | 1617 |
|
|
2020
Q2 | $872K | Buy |
32,900
+21,200
| +181% | +$500K | ﹤0.01% | 6221 |
|
|
2020
Q1 | $192K | Buy |
+11,700
| New | +$257K | ﹤0.01% | 8746 |
|
|
2019
Q4 | – | Sell |
-14,700
| Closed | -$294K | – | 10937 |
|
|
2019
Q3 | $294K | Buy |
+14,700
| New | +$381K | ﹤0.01% | 8346 |
|
|
2019
Q2 | – | Sell |
-9,800
| Closed | -$316K | – | 11040 |
|
|
2019
Q1 | $316K | Buy |
+9,800
| New | +$264K | ﹤0.01% | 7123 |
|
|
2016
Q1 | – | Sell |
-633
| Closed | -$7K | – | 9867 |
|
|
2015
Q4 | $7K | Sell |
633
-24
| -4% | -$248 | ﹤0.01% | 9310 |
|
|
2015
Q3 | $9K | Sell |
657
-66
| -9% | -$1.66K | ﹤0.01% | 9548 |
|
|
2015
Q2 | $22K | Sell |
723
-34
| -4% | -$1.14K | ﹤0.01% | 9992 |
|
|
2015
Q1 | $27K | Sell |
757
-276
| -27% | -$11.6K | ﹤0.01% | 9243 |
|
|
2014
Q4 | $41K | Buy |
1,033
+6
| +0.6% | +$263 | ﹤0.01% | 9398 |
|
|
2014
Q3 | $51K | Buy |
1,027
+127
| +14% | +$7.3K | ﹤0.01% | 9219 |
|
|
2014
Q2 | $58K | Sell |
900
-1,127
| -56% | -$78.4K | ﹤0.01% | 9569 |
|
|
2014
Q1 | $166K | Buy |
2,027
+700
| +53% | +$63.7K | ﹤0.01% | 8361 |
|
|
2013
Q4 | $91K | Sell |
1,327
-1,743
| -57% | -$128K | ﹤0.01% | 8667 |
|
|
2013
Q3 | $290K | Buy |
+3,070
| New | +$400K | ﹤0.01% | 7261 |
|
Other funds holding ALBO
Susquehanna International Group's ALBO Position: Q4 2022 in Review
Susquehanna International Group sold out of Albireo Pharma Inc (ALBO) in Q4 2022, closing a stake of 36,525 shares — an estimated $772K sold.
Susquehanna International Group first reported a position in ALBO in Q2 2013 and held it in 23 quarters. The position peaked at $3.25M in Q2 2021. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2022.
- Susquehanna International Group reported no remaining Albireo Pharma Inc position as of Q4 2022 after selling out during the quarter.
- Susquehanna International Group sold 36,525 Albireo Pharma Inc shares in Q4 2022, an estimated $772K.
- Susquehanna International Group first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 23 quarters.
- Susquehanna International Group's Albireo Pharma Inc position peaked at $3.25M in Q2 2021.
- 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2022.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.